Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'

被引：2
作者：
Downey, C. L. [1 ]
Simpkins, S. A. [1 ]
Holliday, D. L. [1 ]
Jones, J. L. [2 ]
Jordan, L. B. [3 ]
Kulka, J. [4 ]
Hanby, A. M. [1 ]
Speirs, V. [1 ]
机构：
[1] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland
[4] Semmelweis Univ Budapest, Dept Pathol 2, H-1091 Budapest, Hungary
来源：
BRITISH JOURNAL OF CANCER | 2015年 / 112卷 / 11期
关键词：
PROGNOSTIC-SIGNIFICANCE; VALIDATION; STAGE; CARCINOMA; SURVIVAL; TRIAL;
D O I：
10.1038/bjc.2014.571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1833 / 1834
页数：3
相关论文
共 11 条
[1]   Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients [J].
de Kruijf, Esther M. ;
van Nes, Johanna G. H. ;
de Velde, Cornelis J. H. van ;
Putter, Hein ;
Smit, Vincent T. H. B. M. ;
Liefers, Gerrit Jan ;
Kuppen, Peter J. K. ;
Tollenaar, Rob A. E. M. ;
Mesker, Wilma E. .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) :687-696
[2]   Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854) [J].
Dekker, T. J. A. ;
van de Velde, C. J. H. ;
van Pelt, G. W. ;
Kroep, J. R. ;
Julien, J-P. ;
Smit, V. T. H. B. M. ;
Tollenaar, R. A. E. M. ;
Mesker, W. E. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) :371-379
[3]   The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer [J].
Downey, C. L. ;
Simpkins, S. A. ;
White, J. ;
Holliday, D. L. ;
Jones, J. L. ;
Jordan, L. B. ;
Kulka, J. ;
Pollock, S. ;
Rajan, S. S. ;
Thygesen, H. H. ;
Hanby, A. M. ;
Speirs, V. .
BRITISH JOURNAL OF CANCER, 2014, 110 (07) :1744-1747
[4]   The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer [J].
Gujam, F. J. A. ;
Edwards, J. ;
Mohammed, Z. M. A. ;
Going, J. J. ;
McMillan, D. C. .
BRITISH JOURNAL OF CANCER, 2014, 111 (01) :157-165
[5]   Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment [J].
Hanahan, Douglas ;
Coussens, Lisa M. .
CANCER CELL, 2012, 21 (03) :309-322
[6]   The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial [J].
Huijbers, A. ;
Tollenaar, R. A. E. M. ;
v Pelt, G. W. ;
Zeestraten, E. C. M. ;
Dutton, S. ;
McConkey, C. C. ;
Domingo, E. ;
Smit, V. T. H. B. M. ;
Midgley, R. ;
Warren, B. F. ;
Johnstone, E. C. ;
Kerr, D. J. ;
Mesker, W. E. .
ANNALS OF ONCOLOGY, 2013, 24 (01) :179-185
[7]  
Mesker WE, 2007, CELL ONCOL, V29, P387
[8]   Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients [J].
Mesker, Wilma E. ;
Liefers, Gerrit-Jan ;
Junggeburt, Jan M. C. ;
van Pelt, Gabi W. ;
Alberici, Paola ;
Kuppen, Peter J. K. ;
Miranda, Noel F. ;
van Leeuwen, Karin A. M. ;
Morreau, Hans ;
Szuhai, Karoly ;
Tollenaar, Rob A. E. M. ;
Tanke, Hans J. .
CELLULAR ONCOLOGY, 2009, 31 (03) :169-178
[9]   Tubular Carcinoma of the Breast: Further Evidence to Support Its Excellent Prognosis [J].
Rakha, Emad A. ;
Lee, Andrew H. S. ;
Evans, Andrew J. ;
Menon, Sindhu ;
Assad, Nancy Y. ;
Hodi, Zsolt ;
Macmillan, Douglas ;
Blamey, Roger W. ;
Ellis, Ian O. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :99-104
[10]   Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies [J].
Staal, Ewout F. W. Courrech ;
Smit, Vincent T. H. B. M. ;
van Velthuysen, Marie-Louise F. ;
Spitzer-Naaykens, Juliette M. J. ;
Wouters, Michel W. J. M. ;
Mesker, Wilma E. ;
Tollenaar, Rob A. E. M. ;
van Sandick, Johanna W. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) :375-382
12